Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026)
Bausch & Lomb (BLCO) posted Change in Receivables of -$108.0 million for Q1 2026, down 183.08% on a QoQ basis from $130.0 million in Q4 2025, and down 134.78% year-over-year from $310.5 million in Q1 2025.
Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026) Analysis & Trends
Bausch & Lomb's Change in Receivables history runs 6 years deep, the most recent figure standing at -$108.0 million for Q1 2026.
- Quarterly Change in Receivables fell 134.78% year-over-year to -$108.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.0 million (down 3.37% YoY) and the FY2025 annual result came in at $148.0 million, down 34.8% from the prior year.
- Change in Receivables was -$108.0 million for Q1 2026 at Bausch & Lomb, down from $130.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $130.0 million in Q4 2025 and bottomed at -$108.0 million in Q1 2026.
- A 5-year average of $28.4 million and a median of $27.0 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 2700.0% — and 2024, when it sank 825.0%.
- Bausch & Lomb's Change in Receivables stood at $27.0 million in 2022, then jumped by 44.44% to $39.0 million in 2023, then surged by 205.13% to $119.0 million in 2024, then gained by 9.24% to $130.0 million in 2025, then tumbled by 183.08% to -$108.0 million in 2026.
- Business Quant data shows BLCO's Change in Receivables at -$108.0 million in Q1 2026, $130.0 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 146.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 16.86 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 34.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.99 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | -108.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.00 Mn |
| Mar 31, 2026 | -108.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Dec 31, 2023 | 39.00 Mn |
| Dec 31, 2023 | 39.00 Mn |